Cyclerion Therapeutics
CYCN
CYCN
75 hedge funds and large institutions have $140M invested in Cyclerion Therapeutics in 2020 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 20 increasing their positions, 25 reducing their positions, and 11 closing their positions.
Holders
75
Holders Change
-1
Holders Change %
-1.32%
% of All Funds
1.52%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
20
Reduced
25
Closed
11
Calls
$76K
Puts
–
Net Calls
+$76K
Net Calls Change
+$78K
Top Buyers
1 |
SPC
1
Slate Path Capital
New York
|
$37.7M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$10.5M |
3 |
3
T. Rowe Price Associates
Baltimore,
Maryland
|
$4.36M |
4 |
4
Charles Schwab
San Francisco,
California
|
$1.15M |
5 |
5
Morgan Stanley
New York
|
$379K |